Subscribe free

Intestine and Lower Gastrointestinal Tract ·

New nomogram predicts disease-free survival in colon cancer patients

A prognostic study developed validated pre- and post-operative nomograms predicting disease-free survival (DFS) in patients who underwent curative resection for right-sided colon cancer. In a cohort of 822 patients, 1-, 3-, and 5-year DFS rates were found to be 85.6%, 72.5%, and 57.6%, respectively. Key risk factors included age, gender, ASA score, albumin levels, tumor stage, and lymph node involvement. These prediction tools assist clinicians in risk stratification and treatment planning.

Observational Study by Lucocq J, Trinder T (…) Muthukumarasamy G et 3 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

All papers in Intestine and Lower Gastrointestinal Tract →